Browse by People

Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ross, Paul J, Silcocks, Paul, Greenhalf, William, Faluyi, Olusola Olusesan, Ma, Yuk Ting, Wadsley, Jonathan, Rawcliffe, Charlotte Louise, Valle, Juan W and Neoptolemos, John P (2018) ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma. .

Collapse authors list.
Childs, Alexa, Zakeri, Nekisa, Ma, Yuk Ting, O'Rourke, Joanne, Ross, Paul, Hashem, Essam, Hubner, Richard A, Hockenhull, Kimberley, Iwuji, Chinenye, Khan, Sam et al (show 9 more authors) , Palmer, Daniel H ORCID: 0000-0002-7147-5703, Connor, Joanna, Swinson, Daniel, Darby, Suzanne, Braconi, Chiara, Roques, Tom, Yu, Dominic, Luong, Tu Vinh and Meyer, Tim (2021) Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit. BRITISH JOURNAL OF CANCER, 125 (10). pp. 1350-1355.

Collapse authors list.
Primrose, John N, Fox, Richard P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg et al (show 19 more authors) , Wasan, Harpreet, Ross, Paul, Wall, Lucy, Wadsley, Jonathan, Evans, Jeff TR, Stocken, Deborah, Praseedom, Raaj, Ma, Yuk Ting, Davidson, Brian, Neoptolemos, John P, Iveson, Tim, Raftery, James, Zhu, Shihua, Cunningham, David, Garden, O James, Stubbs, Clive, Valle, Juan W, Bridgewater, John and Grp, BILCAP Study (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. LANCET ONCOLOGY, 20 (5). pp. 663-673.

Collapse authors list.
Ghaneh, Paula, Palmer, Daniel, Cicconi, Silvia, Jackson, Richard, Halloran, Christopher Michael ORCID: 0000-0002-5471-4178, Rawcliffe, Charlotte, Sripadam, Rajaram, Mukherjee, Somnath, Soonawalla, Zahir, Wadsley, Jonathan et al (show 26 more authors) , Al-Mukhtar, Ahmed, Dickson, Euan, Graham, Janet, Jiao, Long, Wasan, Harpreet S, Tait, Iain S, Prachalias, Andreas, Ross, Paul, Valle, Juan W, O'Reilly, Derek A, Al-Sarireh, Bilal, Gwynne, Sarah, Ahmed, Irfan, Connolly, Kate, Yim, Kein-Long, Cunningham, David, Armstrong, Thomas, Archer, Caroline, Roberts, Keith, Ma, Yuk Ting, Springfeld, Christoph, Tjaden, Christine, Hackert, Thilo, Büchler, Markus W, Neoptolemos, John P and European Study Group for Pancreatic Cancer, (2022) Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. The lancet. Gastroenterology & hepatology, 8 (2). S2468-1253(22)00348-X-S2468-1253(22)00348-X.

Collapse authors list.
Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari et al (show 11 more authors) , Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S, Hobbs, Claire, Barber, Safia, Ryder, W David, Ramage, John, Davies, Linda M, Bridgewater, John A and Valle, Juan W (2021) Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. LANCET ONCOLOGY, 22 (5). pp. 690-701.

Collapse authors list.
Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J, James, Martin W, Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D, Wall, Lucy, Watkinson, Anthony et al (show 8 more authors) , Hacking, Nigel, Evans, TR Jeffry, Collins, Peter, Hubner, Richard A, Cunningham, David, Primrose, John Neil, Johnson, Philip J ORCID: 0000-0003-1404-0209 and Palmer, Daniel H ORCID: 0000-0002-7147-5703 (2017) Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2 (8). pp. 565-575.

Collapse authors list.
Mosconi, Cristina, O'Rourke, Joanne, Kloeckner, Roman, Sturm, Lukas, Golfieri, Rita, Celsa, Ciro, Fateen, Waleed, Odisio, Bruno C, Garanzini, Enrico Matteo, Peck-Radosavljevic, Markus et al (show 11 more authors) , Borghi, Alberto, Ma, Yuk Ting, Stoehr, Fabian, Bettinger, Dominik, Giuffrida, Paolo, Aithal, Guruprasad P, Lin, Yuan-Mao, Spreafico, Carlo, Giampalma, Emanuela, Johnson, Philip ORCID: 0000-0003-1404-0209 and Cucchetti, Alessandro (2023) Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 46 (4). pp. 449-459.

Ma, Yuk Ting, Leonard, Sarah M, Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B and Palmer, Daniel H ORCID: 0000-0002-7147-5703 (2017) Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. ONCOTARGET, 8 (38). pp. 63635-63645.

Ma, Yuk Ting, Leonard, Sarah M, Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B and Palmer, Daniel H ORCID: 0000-0002-7147-5703 (2017) Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. Oncotarget, 8 (38). pp. 63635-63645.

Johnson, Philip, Dhanaraj, Sofi, Ma, Yuk Ting, Bonnett, Laura ORCID: 0000-0002-6981-9212 and Berhane, Sarah (2020) The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. .

Johnson, Philip J ORCID: 0000-0003-1404-0209, Dhanaraj, Sofi, Berhane, Sarah, Bonnett, Laura ORCID: 0000-0002-6981-9212 and Ma, Yuk Ting (2021) The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. BRITISH JOURNAL OF CANCER, 125 (5). pp. 714-716.